Hypersensitivity reactions to anticancer chemotherapy and monoclonal antibodies: Safety and efficacy of desensitization

Background Hypersensitivity reactions to anticancer chemotherapy and monoclonal antibodies may lead to discontinuation of first-line treatment options. Identification of these reactions can provide specific diagnosis and treatment by rapid drug desensitizations. Objective To determine the hypersensi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of oncology pharmacy practice 2024-08, Vol.30 (5), p.811-822
Hauptverfasser:	Villarreal-González, Rosalaura V, González-Díaz, Sandra, Vidal-Gutiérrez, Oscar, Cruz-de la Cruz, Carlos de la, Pérez-Ibave, Diana C, Garza-Rodríguez, María L
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Cancer Carboplatin Chemotherapy Desensitization, Immunologic - methods Diagnosis Drug Hypersensitivity - etiology Drug Hypersensitivity - immunology Dyspnea Female Humans Hypersensitivity Male Mexico Middle Aged Monoclonal antibodies Neoplasms - drug therapy Neoplasms - immunology Oxaliplatin Paclitaxel Platinum Respiration Rituximab Skin Tests Taxanes Treatment Outcome Urticaria
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!